CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2004-02-11 | ELAN CORP PLC 10% owner | Sale | −10,400 | $1.09 | $11K | 1,908,600 |
| 2004-02-11 | ELAN CORP PLC 10% owner | Sale | −16,600 | $1.08 | $18K | 1,892,000 |
| 2004-02-11 | ELAN CORP PLC 10% owner | Sale | −4,800 | $1.07 | $5K | 1,887,200 |
| 2004-02-11 | ELAN CORP PLC 10% owner | Sale | −44,900 | $1.06 | $48K | 1,842,300 |
| 2004-02-11 | ELAN CORP PLC 10% owner | Sale | −106,900 | $1.05 | $112K | 1,735,400 |
| 2004-02-04 | ELAN CORP PLC 10% owner | Other acquisition · Series B Convertible Preferred Stock | +126,567 | 126,567 | ||
| 2003-11-25 | KANZER STEVE H Director | Purchase | +5,000 | $0.75 | $4K | 819,437 |
| 2003-09-15 | MYRIANTHOPOULOS EVAN Director | Grant or award · Stock Options (right to buy) | +50,000 | $0.90 | $45K | 50,000 |
| 2003-09-15 | MYRIANTHOPOULOS EVAN Director | Grant or award · Stock Warrants | +77,694 | $0.88 | $68K | 120,888 |
| 2003-09-15 | SALOMON PETER MD Director | Grant or award · Stock Options (right to Buy) | +50,000 | $0.90 | $45K | 50,000 |
| 2003-09-15 | SALOMON PETER MD Director | Grant or award · Stock Options (right to buy) | +150,000 | $0.85 | $128K | 150,000 |
| 2003-09-15 | HAIG ALEXANDER M JR GENERAL USA RET Director | Grant or award · Stock Options (right to Buy) | +50,000 | $0.90 | $45K | 50,000 |
| 2003-09-15 | KANZER STEVE H Director | Grant or award | +125,628 | $0.80 | $100K | 125,628 |
| 2003-09-15 | KANZER STEVE H Director | Grant or award · Stock Warrants (right to Buy) | +125,628 | $0.88 | $110K | 125,628 |
| 2003-09-15 | KANZER STEVE H Director | Grant or award · Stock Options (right to Buy) | +50,000 | $0.90 | $45K | 50,000 |
| 2003-09-15 | ELLISON RALPHA CEO/President | Grant or award · Stock Options (right to Buy) | +2,000,000 | $0.85 | $1.7M | 2,000,000 |
| 2003-09-15 | KORNBLUTH ARTHUR ASHER Director | Grant or award · Stock Options (right to Buy) | +50,000 | $0.90 | $45K | 50,000 |
| 2002-12-31 | Salomon Peter Director | Grant or award | +10,000 | $0.35 | $4K | 415,000 |
| 2002-12-12 | ELAN CORP PLC 10% owner | Other acquisition | +500,000 | 2,052,879 | ||
| 2002-10-21 | ELAN CORP PLC 10% owner | Conversion | +1,245,187 | $8.86 | $11.0M | 1,552,879 |
Page 21 of 22 · 422 trades